Efficacy News and Research

RSS
Cerulean closes $24 million Series C financing by Lilly Ventures

Cerulean closes $24 million Series C financing by Lilly Ventures

Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option

Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

Dyax to present data of KALBITOR inhibitor for Angioedema at ACAAI Meeting

Dyax to present data of KALBITOR inhibitor for Angioedema at ACAAI Meeting

Derma Sciences net sales for third quarter 2010 increase 17% to $15,096,134

Derma Sciences net sales for third quarter 2010 increase 17% to $15,096,134

Clinical trial results of Threshold's TH-302 hypoxia-activated prodrug presented at 16th CTOS annual meeting

Clinical trial results of Threshold's TH-302 hypoxia-activated prodrug presented at 16th CTOS annual meeting

U-M researchers develop simple mathematical model to predict whooping cough transmission

U-M researchers develop simple mathematical model to predict whooping cough transmission

SLIT immunotherapy effective for long-term remission of bothersome allergy symptoms

SLIT immunotherapy effective for long-term remission of bothersome allergy symptoms

New report highlights effectiveness of bed rest for pregnant women

New report highlights effectiveness of bed rest for pregnant women

ASN Annual Meeting to highlight six late-breaking clinical trials on nephrology

ASN Annual Meeting to highlight six late-breaking clinical trials on nephrology

Oligomerix receives SBIR Phase II grant to develop drugs for Alzheimer’s disease

Oligomerix receives SBIR Phase II grant to develop drugs for Alzheimer’s disease

NephRx initiates NX001 Phase I clinical trial to prevent DGF in kidney transplant patients

NephRx initiates NX001 Phase I clinical trial to prevent DGF in kidney transplant patients

Think treatments for cancer, diabetes don't grow on trees? Think again

Think treatments for cancer, diabetes don't grow on trees? Think again

BIOTRONIK releases Pulsar-18 stent for treatment of long lesions in superficial femoral, infrapopliteal arteries

BIOTRONIK releases Pulsar-18 stent for treatment of long lesions in superficial femoral, infrapopliteal arteries

Bed rest may not delay preterm births, says Frances Payne professor

Bed rest may not delay preterm births, says Frances Payne professor

Discovery of anti-parasitic drug mechanism could lead to new treatments for filarial diseases

Discovery of anti-parasitic drug mechanism could lead to new treatments for filarial diseases

News stories about cancer contain language that contribute to public uncertainty

News stories about cancer contain language that contribute to public uncertainty

Evotec revenues increase 33% to € 38.8 m during first nine months of 2010

Evotec revenues increase 33% to € 38.8 m during first nine months of 2010

Incyte presents data on INCB28050 Phase IIa trial for rheumatoid arthritis at ACR/ARHP Meeting

Incyte presents data on INCB28050 Phase IIa trial for rheumatoid arthritis at ACR/ARHP Meeting

4SC 2010 first nine months revenue decreases from EUR1.4 million to EUR0.8 million

4SC 2010 first nine months revenue decreases from EUR1.4 million to EUR0.8 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.